Purchase Order 75N94025P00387

This is a $16,000 firm-fixed-price purchase order awarded by the National Cancer Institute, a civilian federal agency, to Ampseq LLC, a for-profit, Asian-Pacific American-owned limited liability company. The contract is for Ampseq to provide Olink technology, which combines specificity and scalability to enable high-throughput, multiplex protein biomarker analysis. This service will help the agency obtain a next-generation proteomics platform using minimal sample volumes. The contract has an...

This is a $20,600 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the Department of Health and Human Services, to Enamine US Inc., a small business contractor. The contract is for single-cell RNA sequencing analysis to investigate the role of GPR110 in cell-type specific neurogenesis. This award supports the NIAAA's mission in advancing translational science and developing prevention and treatment strategies...

The Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism awarded a firm fixed price purchase order valued at thirty-two thousand two hundred eighty dollars to Oxford Nanopore Technologies Inc. for DNA sequencing kits and PromethION flow cell packs. The solicitation requested quotes for six ultra-long DNA sequencing kits and one pack of eight PromethION flow cells to support long read DNA and RNA sequencing on the awardee's...

This is a $32,190 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business. The contract is for testing and sequencing services, including RNA sequencing (bulk and single-cell), DNA sequencing, whole genome/exome sequencing, and metagenomics sequencing, as well as associated...

This firm fixed-price purchase order awards Psomagen Inc. $422,000 to provide RNA sequencing services to the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), from June 2021 through June 2023. The contract supports NIA research on Alzheimer's disease and related dementias by requiring the contractor to construct sequencing libraries from 20 human samples, perform sequencing on an Illumina NovaSeq 6000 platform, and deliver various data files. No set-aside...

This is a $23,500 Firm Fixed Price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Applied Stemcell, Inc. for gene editing services. Applied Stemcell is a minority-owned, woman-owned small business that has previously provided gene editing services to various NIH institutes through federal contracts and grants. The award is for gene editing services to support NIAAA research...

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $13,176.00 firm fixed-price purchase order to Azenta US Inc., doing business as Brooks Life Sciences Inc., for library preparation, Illumina sequencing, and RNA with polyA services. The contract has a completion date of September 30, 2022 and does not utilize any set-aside designations. Azenta US Inc. is a subsidiary of the parent company Azenta, Inc., which has received multiple past federal contract awards from agencies...

This is a $110,137.50 firm fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency under the Department of Health and Human Services, to Seqmatic, LLC, a minority-owned, Asian-Pacific American-owned small business based in Fremont, California. The contract is for histology services to support research on vascular senescence, which involves staining tissues to identify and study senescent cells in vascular aging and age-related diseases using preclinical...

This is a $64,800 firm-fixed price purchase order awarded by the National Institute on Aging (NIA), part of the National Institutes of Health (NIH), to Psomagen Inc. for RNA sequencing services to support neurodegenerative disease research. The contract has a period of performance from August 1, 2024 to December 31, 2024. Psomagen will provide total RNA sequencing, including library preparation, sequencing, and data delivery, for 324 human samples. This is a non-competitive award, as Psomagen...

This firm fixed-price purchase order was awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency, to Qiagen, LLC for Sequencing (NGS) Services in the amount of $24,991.66. The award has an ultimate completion date of July 31, 2024 and a ceiling value of $23,514.01. There is no set-aside designation associated with this contract. Qiagen, LLC is a division of the parent company Qiagen N.V., an international provider of sample and assay technologies. Qiagen...